HTA in the Czech Republic: Still Behind

  • Vladimír Rogalewicz
  • Ivana Kubátová
  • Gleb Donin
  • Tomáš Doležal
  • Klára Lamblová
  • Jana Bartáková
  • Peter Kneppo
Conference paper
Part of the IFMBE Proceedings book series (IFMBE, volume 68/2)


The paper analyses the current state of HTA implementation and organisational initiatives in the Czech Republic. Although there have been some substantial elements of HTA applied in the decision process of pharmaceutical reimbursement since 2008, HTA methods are rather disregarded in other technologies. Since there is practically no demand for HTA studies from payers and state representatives, HTA has been cultivated above all by interested individuals and small academic research groups around them. These groups have succeeded in keeping pace with the global development both in theoretical and practical issues (among others in HTA methods for medical devices), however, the practical production of country specific HTA studies is rather rare. The main problem is non-existence of a national commonly accepted methodology and a legal framework. At least two attempts to establish a regular HTA process initiated by the Ministry of Health were destined to fail due to frequent personal changes in the Ministry. We discuss topical issues to be solved on the way to a national HTA system, and present our vision of a possible solution.


HTA Czech Republic Current state 


Conflict of Interests

The authors declare no conflict of interests.


  1. 1.
    Grundová, D., Malina, A., Šimek, J., Křížová, E.: Co je hodnocení technologií (Technology Assessment-TA). Praktický lékař 82, 83–88 (2002)Google Scholar
  2. 2.
    Křížová, E., Šimek, J., Malina, A., Grundová, D., Trčková, M.: Zdravotnické technologie v empirickém šetření. Hodnocení dostupnosti a dalších etických aspektů u vybraných technologií v čekém prostředí. Praktický lékař 83, 690–694 (2003)Google Scholar
  3. 3.
    Žaloudík, J., Dušek, L., Vyzula, R.: Koncepce HTA pro onkologii. Klinická onkologie 17, 5–10 (2004)Google Scholar
  4. 4.
    Dlouhý, M., Barták, M., Hlavácek, A., Kokavec, P., Malina, A.: Zdravotnické technologie v ČR [A need for health technology assessment in the Czech Republic]. Zdravotnictví v České republice 11, 136–138 (2008)Google Scholar
  5. 5.
    ČFES: Doporučené postupy České farmakoekonomické společnosti (ČFES) pro zdravotně-ekonomická hodnocení v ČR. Česká farmakoekonomická společnost, Praha (October 2016)Google Scholar
  6. 6.
    SÚKL: Postup pro posuzování analýzy nákladové efektivity. SP-CAU-028. Státní úřad pro kontrolu léčiv, Praha (2017)Google Scholar
  7. 7.
    Loblova, O.: Three worlds of health technology assessment: explaining patterns of diffusion of HTA agencies in Europe. Health Economics Policy and Law 11, 253–273 (2016)Google Scholar
  8. 8.
    Dáme HTA zelenou? ( Sdružení Občan z.s., Praha (2012)
  9. 9.
    Löblová, O.: Who’s afraid of institutionalizing health technology assessment (HTA)?: Interests and policy positions on HTA in the Czech Republic. Health Economics, Policy and Law 1–25 (2017)Google Scholar
  10. 10.
    Gulacsi, L., Rotar, A., Niewada, M., Loblova, O., Rencz, F., Petrova, G., Boncz, I., Klazinga, N.: Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria. European Journal of Health Economics 15, S13–S25 (2014)Google Scholar
  11. 11.
    Rosina, J., Rogalewicz, V., Ivlev, I., Juřičková, I., Donin, G., Jantosová, N., Vacek, J., Otawová, R., Kneppo, P.: Health Technology Assessment for Medical Devices. Lekar a technika - Clinician and Technology 44, 23–36 (2014)Google Scholar
  12. 12.
    Drummond, M., Griffin, A., Tarricone, R.: Economic evaluation for devices and drugs, same or different? Value in Health 12, 402–404 (2009)Google Scholar
  13. 13.
    Rogalewicz, V., Jurickova, I.: Specificities of Medical Devices Affecting Health Technology Assessment Methodology. Proceedings IWBBIO2014: International Work-Conference on Bioinformatics and Biomedical Engineering, Vols 1 and 2, 1229–1234 (2014)Google Scholar
  14. 14.
    Rogalewicz, V.: Health technology assessment as a tool for medical devices management in hospitals. 2015 E-Health and Bioengineering Conference (EHB) (2015)Google Scholar
  15. 15.
    Ivlev, I., Kneppo, P., Bartak, M.: Multicriteria decision analysis: a multifaceted approach to medical equipment management. Technological and Economic Development of Economy 20, 576–589 (2014)Google Scholar
  16. 16.
    Kubátová, I.: Application of value engineering and multiple-criteria decision making in medical devices assessment [Využití hodnotového inženýrství a multikriteriálního rozhodování při hodnocení zdravotnické techniky]. PhD Thesis, Faculty of Biomedical Engineering, pp. 120. Czech Technical University in Prague, Kladno (2015)Google Scholar
  17. 17.
    Ivlev, I., Kneppo, P., Bartak, M.: Method for selecting expert groups and determining the importance of expert’ judgments for the purpose of managerial decision-making tasks in health system. E & M Ekonomie a Management 18, 57–72 (2015)Google Scholar
  18. 18.
    Rogalewicz, V., Ujhelyiova, A., Pousek, L., Sinkorova, V., Kneppo, P.: Health Technology Assessment and Medical Devices. 2011 E-Health and Bioengineering Conference (EHB) (2011)Google Scholar
  19. 19.
    Donin, G., Kneppo, P.: Medical Device Procurement Tracking System: Concept and Methods. In: Lacković, I., Vasic, D. (eds.) 6th European Conference of the International Federation for Medical and Biological Engineering, IFMBE Proceedings vol. 45, pp. 629–632. Springer International Publishing (2015)Google Scholar
  20. 20.
    Donin, G., Barták, M., Kneppo, P.: Estimation of medical equipment prices – a case study of tomotherapy equipment in the Czech Republic. Journal of Business Economics and Management 18, 1193–1211 (2017)Google Scholar
  21. 21.
    Királyová, E., Steklá, M., Donin, G.: Selection of a PET/CT scanner for the department of nuclear medicine. 6th IEEE International Conference on E-Health and Bioengineering, EHB 2017, pp. 329–332. Grigore T. Popa University of Medicine and Pharmacy, Sinaia; Romania (2017)Google Scholar
  22. 22.
    Rogalewicz, V., Matuskova, K., Zavadil, M., Vaclavikova, A., Kamensky, V.: POCT cost effectiveness case study on the way to a HB-HTA unit. Value in Health 20, A600-A600 (2017)Google Scholar
  23. 23.
    Ciani, O., Federici, C., Tarricone, R.: Current and Future Trends in the HTA of Medical Devices. XIV Mediterranean Conference on Medical and Biological Engineering and Computing MEDICON 2016, IFMBE Proceedings, vol 57, pp. 1345–1348. Springer International Publishing, Cham (2016)Google Scholar
  24. 24.
    Rothery, C., Claxton, K., Palmer, S., Epstein, D., Tarricone, R., Sculpher, M.: Characterising Uncertainty in the Assessment of Medical Devices and Determining Future Research Needs. Health Economics 26, 109–123 (2017)Google Scholar
  25. 25.
    Fuchs, S., Olberg, B., Panteli, D., Perleth, M., Busse, R.: HTA of medical devices: Challenges and ideas for the future from a European perspective. Health Policy 121, 215–229 (2017)Google Scholar
  26. 26.
    Fuchs, S., Olberg, B., Panteli, D., Busse, R.: Health Technology Assessment of medical devices in Europe: processes, practices, and methods. International Journal of Technology Assessment in Health Care 32, 246–255 (2016)Google Scholar
  27. 27.
    Broekhuizen, H., Groothuis-Oudshoorn, C.G.M., van Til, J.A., Hummel, J.M., IJzerman, M.J.: A Review and Classification of Approaches for Dealing with Uncertainty in Multi-Criteria Decision Analysis for Healthcare Decisions. Pharmacoeconomics 33, 445–455 (2015)Google Scholar
  28. 28.
    Pecchia, L., Mirarchi, L., Doniacovo, R., Marsico, V., Bracale, M.: Health Technology Assessment for a Service Contract: a new method for decisional tools. 11th International Congress of the IUPESM/World Congress on Medical Physics and Biomedical Engineering, IFMBE Proceedings vol. 25, pp. 105–108. Springer, Berlin, Heidelberg (2009)Google Scholar
  29. 29.
    Schnell-Inderst, P., Mayer, J., Lauterberg, J., Hunger, T., Arvandi, M., Conrads-Frank, A., Nachtnebel, A., Wild, C., Siebert, U.: Health technology assessment of medical devices: What is different? An overview of three European projects. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 109, 309–318 (2015)Google Scholar
  30. 30.
    Löblová, O.: When Epistemic Communities Fail: Exploring the Mechanism of Policy Influence. Policy Studies Journal (2017)

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Vladimír Rogalewicz
    • 1
  • Ivana Kubátová
    • 1
  • Gleb Donin
    • 1
  • Tomáš Doležal
    • 2
  • Klára Lamblová
    • 2
  • Jana Bartáková
    • 2
  • Peter Kneppo
    • 1
  1. 1.CzechHTA, Faculty of Biomedical EngineeringCzech Technical University in PraguePragueCzech Republic
  2. 2.iHETAPragueCzech Republic

Personalised recommendations